Notice of Award of a Single-Source Cooperative Agreement To Fund the Tanzanian Ministry of Health, 16016 [2023-05253]
Download as PDF
<![CDATA[
16016
Federal Register / Vol. 88, No. 50 / Wednesday, March 15, 2023 / Notices
funds. Funding amounts for years 2–5
will be set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003).
Period of Performance: September 30,
2023 through September 29, 2028.
Dated: March 9, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2023–05254 Filed 3–14–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Single-Source
Cooperative Agreement To Fund the
Tanzanian Ministry of Health
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $5,000,000, for
Year 1 funding to the Tanzania Ministry
of Health (MOH). The award will
strengthen capacity and maximize the
efficiency in achieving HIV epidemic
control and sustaining the MOH
response to the HIV epidemic in the
United Republic of Tanzania. Funding
amounts for years 2–5 will be set at
continuation.
DATES: The period for this award will be
September 30, 2023, through September
29, 2028.
FOR FURTHER INFORMATION CONTACT:
Gbolahan Cole, Center for Global
Health, Centers for Disease Control and
Prevention, 2448 Albert Luthuli Rd.,
NIMR Complex | P.O. Box 9123, Dar es
Salaam, Tanzania, Telephone: 012–424–
9000, Email: yka7@cdc.gov.
SUPPLEMENTARY INFORMATION: The
single-source award will support the
Tanzanian MOH to ensure a
comprehensive, coordinated, and
strategic approach to the HIV response
by organizing policies and
interventions: along the continuum of
HIV prevention, identification,
treatment, and support; focusing on
specific vulnerable populations;
supported by reliable epidemiologic and
program data.
The MOH is in a unique position to
conduct this work, as it is currently the
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:48 Mar 14, 2023
Jkt 259001
only appropriate and qualified entity to
conduct a specific set of activities
supportive of the CDC and PEPFAR
goals for enhancing HIV prevention,
care, and treatment services.
Summary of the Award
Recipient: Tanzanian Ministry of
Health (MOH).
Purpose of the Award: The purpose of
this award is to is to strengthen capacity
and maximize the efficiency in
achieving HIV epidemic control and
sustaining the MOH response to the HIV
epidemic in the United Republic of
Tanzania.
Amount of Award: The approximate
year 1 funding amount will be
$5,000,000 in Federal Fiscal Year (FYY)
2023 funds, subject to the availability of
funds. Funding amounts for years 2–5
will be set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003).
Period of Performance: September 30,
2023 through September 29, 2028.
Dated: March 9, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2023–05253 Filed 3–14–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Board of Scientific
Counselors, Deputy Director for
Infectious Diseases
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Board of
Scientific Counselors, Deputy Director
for Infectious Diseases (BSC, DDID). The
BSC, DDID consists of 17 experts from
authorities knowledgeable in the fields
relevant to the issues addressed by
CDC’s infectious disease national
centers (e.g., respiratory diseases,
healthcare-associated infections,
antimicrobial resistance, foodborne
diseases, zoonotic and vector-borne
diseases, sexually transmitted diseases,
preparedness) and related specialties,
SUMMARY:
PO 00000
Frm 00065
Fmt 4703
Sfmt 4703
including clinical and public health
practice (including state and local
health departments), laboratory practice,
research, diagnostics, microbiology,
immunology, molecular biology,
bioinformatics, infectious disease
modeling and outbreak analytics, health
policy/communications, and industry.
DATES: Nominations for membership on
the BSC, DDID must be received no later
than April 14, 2023. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
mailed to the Centers for Disease
Control and Prevention, BSC, DDID,
1600 Clifton Road NE, Mailstop H16–5,
Atlanta, Georgia 30329–4027 or emailed
to SWiley@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Sarah Wiley, M.P.H., Senior Advisor,
National Center for Emerging and
Zoonotic Infectious Diseases, CDC, 1600
Clifton Road NE, Mailstop H16–5,
Atlanta, Georgia 30329–4027.
Telephone: (404) 639–4840; Email:
SWiley@cdc.gov.
SUPPLEMENTARY INFORMATION:
Nominations are sought for individuals
who have the expertise and
qualifications necessary to contribute to
the accomplishment of the objectives of
the BSC, DDID. Nominees will be
selected based on expertise in the fields
of infectious diseases and related
specialties, including those listed above.
Federal employees will not be
considered for membership. Members
may be invited to serve for up to fouryear terms. Selection of members is
based on candidates’ qualifications to
contribute to the accomplishment of
BSC, DDID objectives (https://
www.cdc.gov/ddid/bsc.html).
HHS policy stipulates that committee
membership be balanced in terms of
points of view represented and the
committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on Federal workgroups or
prior experience serving on a Federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees, requiring the filing of
financial disclosure reports at the
beginning of and annually during their
terms. CDC reviews potential candidates
E:\FR\FM\15MRN1.SGM
15MRN1
]]>Agencies
[Federal Register Volume 88, Number 50 (Wednesday, March 15, 2023)]
[Notices]
[Page 16016]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05253]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Single-Source Cooperative Agreement To Fund
the Tanzanian Ministry of Health
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award of approximately $5,000,000, for Year 1 funding to the Tanzania
Ministry of Health (MOH). The award will strengthen capacity and
maximize the efficiency in achieving HIV epidemic control and
sustaining the MOH response to the HIV epidemic in the United Republic
of Tanzania. Funding amounts for years 2-5 will be set at continuation.
DATES: The period for this award will be September 30, 2023, through
September 29, 2028.
FOR FURTHER INFORMATION CONTACT: Gbolahan Cole, Center for Global
Health, Centers for Disease Control and Prevention, 2448 Albert Luthuli
Rd., NIMR Complex [verbar] P.O. Box 9123, Dar es Salaam, Tanzania,
Telephone: 012-424-9000, Email: [email protected].
SUPPLEMENTARY INFORMATION: The single-source award will support the
Tanzanian MOH to ensure a comprehensive, coordinated, and strategic
approach to the HIV response by organizing policies and interventions:
along the continuum of HIV prevention, identification, treatment, and
support; focusing on specific vulnerable populations; supported by
reliable epidemiologic and program data.
The MOH is in a unique position to conduct this work, as it is
currently the only appropriate and qualified entity to conduct a
specific set of activities supportive of the CDC and PEPFAR goals for
enhancing HIV prevention, care, and treatment services.
Summary of the Award
Recipient: Tanzanian Ministry of Health (MOH).
Purpose of the Award: The purpose of this award is to is to
strengthen capacity and maximize the efficiency in achieving HIV
epidemic control and sustaining the MOH response to the HIV epidemic in
the United Republic of Tanzania.
Amount of Award: The approximate year 1 funding amount will be
$5,000,000 in Federal Fiscal Year (FYY) 2023 funds, subject to the
availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003).
Period of Performance: September 30, 2023 through September 29,
2028.
Dated: March 9, 2023.
Terrance Perry,
Chief Grants Management Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023-05253 Filed 3-14-23; 8:45 am]
BILLING CODE 4163-18-P
